212 related articles for article (PubMed ID: 861060)
1. Effect of dipyridamole and its monoglucuronide derivative on adenosine uptake by human platelets and ADP-induced platelet aggregation.
Subbarao K; Rucinski B; Niewiarowski S
Biochem Pharmacol; 1977 May; 26(9):906-7. PubMed ID: 861060
[No Abstract] [Full Text] [Related]
2. Proceedings: Binding of (14C) dipyradamole (RA 8) to platelets and inhibition of ADP induced platelet aggregation.
Subbarao K; Rucinski B; Niewarowski S
Thromb Diath Haemorrh; 1975 Nov; 34(2):552-3. PubMed ID: 1198424
[No Abstract] [Full Text] [Related]
3. Binding of dipyridamole to human platelets and to alpha1 acid glycoprotein and its significance for the inhibition of adenosine uptake.
Subbarao K; Rucinski B; Rausch MA; Schmid K; Niewiarowski S
J Clin Invest; 1977 Oct; 60(4):936-43. PubMed ID: 893681
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of the antiplatelet action of dipyridamole in whole blood: modulation of adenosine concentration and activity.
Gresele P; Arnout J; Deckmyn H; Vermylen J
Thromb Haemost; 1986 Feb; 55(1):12-8. PubMed ID: 3704998
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory mechanism of dipyridamole on platelet aggregation ex vivo.
Fukawa K; Saitoh K; Irino O; Ohkubo K; Hashimoto S
Thromb Res; 1982 Aug; 27(3):333-40. PubMed ID: 6291192
[TBL] [Abstract][Full Text] [Related]
6. Cilostazol and dipyridamole synergistically inhibit human platelet aggregation.
Liu Y; Cone J; Le SN; Fong M; Tao L; Shoaf SE; Bricmont P; Czerwiec FS; Kambayashi J; Yoshitake M; Sun B
J Cardiovasc Pharmacol; 2004 Aug; 44(2):266-73. PubMed ID: 15243309
[TBL] [Abstract][Full Text] [Related]
7. Effect of dipyridamole-like compound (R-E 244) on aggregation and cyclic AMP accumulation in human platelets.
Söderbäck U; Sollevi A
Thromb Res; 1991 Nov; 64(3):355-62. PubMed ID: 1666697
[TBL] [Abstract][Full Text] [Related]
8. Adenosine-3',5'-diphosphate and coenzyme A--effects on platelet function.
Subbarao K; Kuchibhotla J
Biochem Pharmacol; 1978; 27(8):1193-6. PubMed ID: 697919
[No Abstract] [Full Text] [Related]
9. Adenosine metabolism in platelets and plasma.
Caen JP; Jenkins CS; Michel H; Chivot JJ; Levy-Toledano S; Rendu F
Ser Haematol; 1973; 6(3):317-32. PubMed ID: 4777837
[No Abstract] [Full Text] [Related]
10. Effect of dipyridamol on the electrokinetic potential of platelets.
Aznar J; Vallés J
Rev Esp Fisiol; 1974 Jun; 30(2):77-9. PubMed ID: 4278529
[No Abstract] [Full Text] [Related]
11. Interactions between dipyridamole and prostaglandin E1 with ADP-induced aggregation of rat platelet in whole blood.
Touqui L; Hatmi M; Vargaftig BB
Thromb Haemost; 1984 Jul; 51(3):410. PubMed ID: 6541815
[No Abstract] [Full Text] [Related]
12. In vitro evaluation of inhibitors of platelet release and aggregation.
Rosenberg JC; Sell TL
Arch Surg; 1975 Aug; 110(8):980-3. PubMed ID: 168838
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of the antiplatelet action of adenosine in whole blood by dipyridamole or dilazep and the cAMP phosphodiesterase inhibitor, RA 233.
Dawicki DD; Agarwal KC; Parks RE
Thromb Res; 1986 Jul; 43(2):161-75. PubMed ID: 3016942
[TBL] [Abstract][Full Text] [Related]
14. Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline.
Michal F; Motamed M
Br J Pharmacol; 1976 Feb; 56(2):209-18. PubMed ID: 1252669
[TBL] [Abstract][Full Text] [Related]
15. Evidence for an anti-aggregatory effect of adenosine at physiological concentrations and for its role in the action of dipyridamole.
Edlund A; Sidén A; Sollevi A
Thromb Res; 1987 Jan; 45(2):183-90. PubMed ID: 3563983
[TBL] [Abstract][Full Text] [Related]
16. [Effect of aggregation inducers and inhibitors on the functional properties and the ultrastructure of platelets].
Lakin KM; Makarow WA; Mular AG
Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):849-52. PubMed ID: 94877
[TBL] [Abstract][Full Text] [Related]
17. On the mechanism of plasmin-induced platelet aggregation. Implications of the dual role of granule ADP.
Ishii-Watabe A; Uchida E; Mizuguchi H; Hayakawa T
Biochem Pharmacol; 2000 Jun; 59(11):1345-55. PubMed ID: 10751543
[TBL] [Abstract][Full Text] [Related]
18. Effects of combining three different antiplatelet agents on platelets and leukocytes in whole blood in vitro.
Zhao L; Bath P; Heptinstall S
Br J Pharmacol; 2001 Sep; 134(2):353-8. PubMed ID: 11564653
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of ADP-induced platelet aggregation prevent fibrinogen binding to rabbit platelets and cause rapid deaggregation and dissociation of bound fibrinogen.
Harfenist EJ; Packham MA; Kinlough-Rathbone RL; Mustard JF
J Lab Clin Med; 1981 May; 97(5):680-8. PubMed ID: 6783712
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of aggregation and secretion of human platelets by quercetin and other flavonoids: structure-activity relationships.
Beretz A; Cazenave JP; Anton R
Agents Actions; 1982 Jul; 12(3):382-7. PubMed ID: 6182778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
